1. Home
  2. INAB vs DLPN Comparison

INAB vs DLPN Comparison

Compare INAB & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

N/A

Current Price

$0.82

Market Cap

11.8M

Sector

Health Care

ML Signal

N/A

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

N/A

Current Price

$1.00

Market Cap

13.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
INAB
DLPN
Founded
2016
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
13.4M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
INAB
DLPN
Price
$0.82
$1.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
★ 35.4K
9.6K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 77.87
EPS
N/A
★ N/A
Revenue
N/A
★ $56,699,389.00
Revenue This Year
N/A
$4.88
Revenue Next Year
N/A
$3.25
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 9.70
52 Week Low
$0.80
$0.90
52 Week High
$2.73
$1.87

Technical Indicators

Market Signals
Indicator
INAB
DLPN
Relative Strength Index (RSI) 34.98 51.25
Support Level N/A $0.93
Resistance Level $1.50 $1.20
Average True Range (ATR) 0.08 0.06
MACD -0.01 0.01
Stochastic Oscillator 2.00 62.50

Price Performance

Historical Comparison
INAB
DLPN

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

Share on Social Networks: